Medpace Holdings, Inc.
MEDP· Nasdaq
Released Jul 26, 2021, after the close
10-Q filed Jul 27, 2021, 27 days after period end · 0001564590-21-038287
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $278.29M | $205.00M | $214.10M | $170.14M |
| Net Income | $39.93M | $24.10M | $27.46M | $16.57M |
| EPS Diluted |
Medpace Holdings, Inc. · CIK 1668397 · Engraved from SEC EDGAR
| $1.06 |
| $0.64 |
| $0.73 |
| $0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.